Shown values refer to:
Cancer diagnosis | Year (descending) | |||
---|---|---|---|---|
2009-2018 | 2010-2019 | 2011-2020 | 2012-2021 | |
All malignancies | 1.3 | 1.2 | 1.2 | 1.2 |
Leukaemias, myeloproliferative and myelodysplastic diseases | 1.3 | 1.3 | 1.3 | 1.3 |
Lymphomas and reticuloendothelial neoplasms | 1.7 | 1.7 | 1.7 | 1.7 |
CNS and miscellaneous intracranial and intraspinal neoplasms | 1.2 | 1.2 | 1.2 | 1.2 |
Neuroblastoma and other peripheral nervous cell tumours | 1.4 | 1.3 | 1.3 | 1.3 |
Retinoblastoma | 1.1 | 1.1 | 1.1 | 1.1 |
Renal tumours | 0.9 | 0.9 | 0.9 | 0.9 |
Hepatic tumours | 1.2 | 1.3 | 1.3 | 1.3 |
Malignant bone tumours | 1.3 | 1.3 | 1.3 | 1.3 |
Soft tissue and other extraosseous sarcomas | 1.3 | 1.3 | 1.2 | 1.2 |
Germ cell tumours, trophoblastic tumours and neoplasms of gonads | 1.0 | 1.0 | 0.9 | 1.0 |
Other malignant epithelial neoplasms and malignant melanomas | 0.7 | 0.7 | 0.7 | 0.7 |
Others and unspecified malignant neoplasms | 0.9 | 0.9 | 1.0 | 1.0 |
The Federal Health Monitoring System 18. Apr 2024